Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q1 Loss of 55c/Share

Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q1 EPS of ($0.55), $0.01 worse than the analyst estimate of ($0.54).

For earnings history and earnings-related data on Aegerion Pharmaceuticals, Inc. (AEGR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• CAE, Inc. (CAE) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY27 EPS Guidance
• Bernstein SocGen Group Downgrades Bridgestone Corp. (5108:JP) (BRDCY) to Market Perform